Abstract
Objective To assess whether antibiotic duration (AD) and one-year antibiotic-free days (AFD) are associated with key in-hospital and post-discharge outcomes among critically ill adults.
Design Retrospective observational study.
Setting Quaternary care academic medical center in the United States.
Patients A total of 126 critically ill adults, mean age 68.1 years (±15.6), 51.6% male, median APACHE II score of 20.5 (IQR 15–25); 71.4% met sepsis criteria.
Methods Patient demographics, clinical characteristics, antibiotic use, and outcomes were collected over one year. Secondary infection was defined as ≥3 consecutive antibiotic days within a year following the index sepsis admission. Multivariate analyses adjusted for age, APACHE II score, gender, and glucocorticosteroid dose.
Results Within 30 days, longer AD correlated with increased hospital stay (p<0.001) with each additional day of antibiotics associated with 0.37 – 0.39 extra days of hospitalization in univariate and multivariate analyses, respectively. In septic patients specifically, AFD significantly correlated with hospital length-of-stay in both univariate (p=0.023) and multivariate analyses (p=0.002), with no impact from infection type on AD or AFD. Fewer AFD correlated with higher secondary bacteremia rates in unadjusted analysis (p=0.023 overall), but this effect was not significant after multivariable adjustment. Neither AD nor AFD predicted one-year mortality or readmission.
Conclusions Extended antibiotic duration in critically ill patients prolonged hospital stays without providing mortality or readmission benefits. These findings underscore the importance of robust antibiotic stewardship, where shorter, targeted regimens can reduce unintended complications and improve overall outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the National Institute of General Medical Sciences, grants # K08GM138825 and R35GM150695
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical Approval was provided by The Penn State College of Medicine Institutional Review Board of the Human Studies Protection Office on July 30, 2020 (ref# 15328). All methods were carried out in accordance with relevant institutional guidelines and regulations.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding: This study was funded by the National Institute of General Medical Sciences, grants # K08GM138825 and R35GM150695 (ASB)
Conflicts: The authors have no conflicts of interest to declare.
Data Availability: Data are available from the authors on reasonable request
Ethical Approval was provided by The Penn State College of Medicine Institutional Review Board of the Human Studies Protection Office on July 30, 2020 (ref# 15328). All methods were carried out in accordance with relevant institutional guidelines and regulations.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
